Author:
Ho Liam Pock,Tan Chuen Wen,Ng Heng Joo,Jason Chay Wai Mun,Tan Jing Yuan,Goh Su Yen
Abstract
COVID-19 and metabolic syndrome, though seemingly different disorders, appear to share certain common pathogenic components, especially in the development of COVID-19-associated diabetes mellitus. The similarities include impairment in immunoendothelial, gastrointestinal, pancreatic, adipose and mitochondrial functions, with several critical micronutrients undergirding the intricate interactions among these dysfunctions. This discussion aims to highlight the parallels between COVID-19 and metabolic syndrome and to propose the possibility of SARS-CoV-2 being a prototype of an acquired etiological agent which can eventually lead to the development of classical metabolic syndrome. Based on the proposed model, the discussion will include the implication for early management of COVID-19 and metabolic syndrome.
Subject
Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology
Reference109 articles.
1. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized with COVID-19 in the New York City Area;JAMA,2020
2. New-Onset Diabetes in COVID-19;N. Engl. J. Med.,2020
3. Clinical Characteristics of COVID-19 Patients with Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study;Am. J. Gastroenterol.,2020
4. A comprehensive definition for metabolic syndrome;Dis. Model. Mech.,2009
5. Incidence of newly diagnosed diabetes after COVID-19;Diabetologia,2022